The impact of vitamin D on fetal and neonatal lung maturation. A systematic review

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 308, Issue 7, 2015, Pages L587-L602

  Lykkedegn, Sine ^a,b   Sorensen, Grith Lykke ^b   Beck Nielsen, Signe Sparre ^a,b   Christesen, Henrik Thybo ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Fetus; Lung; Neonate; Preterm; Surfactant; Vitamin D

Indexed keywords

LUNG SURFACTANT; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; CELL PROLIFERATION; FETUS LUNG MATURATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG DEVELOPMENT; LUNG DYSPLASIA; MASS FRAGMENTOGRAPHY; MATURATION; NEONATAL LUNG MATURATION; NONHUMAN; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME; SYSTEMATIC REVIEW; VITAMIN D DEFICIENCY; ANIMAL; BRONCHOPULMONARY DYSPLASIA; COMPLICATION; EMBRYOLOGY; FEMALE; FETUS DEVELOPMENT; GROWTH, DEVELOPMENT AND AGING; LUNG; NEWBORN; PHYSIOLOGY; PREGNANCY; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

ANIMALS; BRONCHOPULMONARY DYSPLASIA; FEMALE; FETAL DEVELOPMENT; HUMANS; INFANT, NEWBORN; LUNG; PREGNANCY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84926362127     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00117.2014     Document Type: Article

References (109)

1. Akella A, Deshpande SB. Pulmonary surfactant and their role in pathophysiology of lung disorders. Indian J Exp Biol 51: 5–22, 2013.
2. Altman M, Vanpee M, Cnattingius S, Norman M. Risk factors for acute respiratory morbidity in moderately preterm infants. Paediatr Perinat Epidemiol 27: 172–181, 2013.
3. Andersen LB, Abrahamsen B, Dalgard C, Kyhl HB, Beck-Nielsen SS, Frost-Nielsen M, Jorgensen JS, Barington T, Christesen HT. Parity and tanned white skin as novel predictors of vitamin D status in early pregnancy: a population-based cohort study. Clin Endocrinol 79: 333–341, 2013.
4. Ataseven F, Aygün C, Okuyucu A, Bedir A, Kücük Y, Kücüködük S. Is Vitamin D deficiency a risk factor for respiratory distress syndrome? Int J Vitam Nutr Res 83: 232–237, 2013.
5. Backström MC, Mäki R, Kuusela AL, Sievänen H, Koivisto AM, Ikonen RS, Kouri T, Mäki M. Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants. Arch Dis Child Fetal Neonatal Ed 80: F161–F166, 1999.
6. Bailey D, Perumal N, Yazdanpanah M, Al Mahmud A, Baqui AH, Adeli K, Roth DE. Maternal-fetal-infant dynamics of the C3-epimer of 25-hydroxyvitamin D. Clin Biochem 47: 816–822, 2014.
7. Baker JH, Lindsey JR, Weisbroth HS. The Laboratory Rat, Volume 1, Biology and Diseases. Amsterdam, The Netherlands: Elsevier, 2013.
8. Ballard PL, Merrill JD, Godinez RI, Godinez MH, Truog WE, Ballard RA. Surfactant protein profile of pulmonary surfactant in premature infants. Am J Respir Crit Care Med 168: 1123–1128, 2003.
9. Berry D, Hyppönen E. Determinants of vitamin D status: focus on genetic variations. Curr Opin Nephrol Hypertens 20: 331–336, 2011.
10. Bersani I, Speer C, Kunzmann S. Surfactant proteins A and D in pulmonary diseases of preterm infants. Expert Rev Anti Infect Ther 10: 573–584, 2012.
11. Boggaram V, Smith ME, Mendelson CR. Regulation of expression of the gene encoding the major surfactant. Protein (SP-A) in human fetal lung in vitro. J Biol Chem 264: 11421–11427, 1988.
12. Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D, Lips P. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab 98: E1283–E1304, 2013.
13. Brownfoot F, Gagiardi D, Bain E, Middleton P, Crowther C. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 8: CD006764, 2013.
14. Burri PH. Fetal and postnatal development of the lung. Annu Rev Physiol 46: 617–628, 1984.
15. Camargo CA, Ingham T, Wickens K, Thadhani R, Silvers KM, Epton MJ, Town GI, Pattemore PK, Espinola JA, Crane J. Cord- blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Paediatrics 127: e180–e187, 2011.
16. Camargo CAJ, Rifas-Shiman SL, Litonjua AA, Rich-Edwards JW, Weiss ST, Gold DR, Kleinman K, Gillman MW. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr 85: 788–795, 2007.
17. Chishimba L, Thickett D, Stockley R, Wood A. The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax 65: 456–462, 2010.
18. Christesen HT, Andersen LB. Reply to: ‘Vitamin D deficiency during pregnancy: confronting the issues’. Clin Endocrinol 81: 155–156, 2014.
19. Christesen HT, Elvander C, Lamond RF, Jorgensen JS. The impact of vitamin D in pregnancy on extraskeletal health in children: A systematic review. Acta Obstet Gynecol Scand 91: 1368–1380, 2012.
20. Christesen HT, Falkenberg T, Lamond RF, Jorgensen J. The impact of Vitamin D on pregnancy: A systematic review. Acta Obstet Gynecol Scand 91: 1357–1367, 2012.
21. Darlow B, Graham P. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev 5: 1–58, 2011.
22. Dawodu A, Nath R. High prevalence of moderately severe vitamin D deficiency in preterm infants. Pediatr Int 53: 207–210, 2011.
23. 22a.Di Renzo GC, Anceschi MM, Cosmi EV. Lung surfactant enhancement in utero. Eur J Obstet Gynecol Reprod Biol 32: 1–11, 1989.
24. Edelson JD, Chan S, Jassal D, Post M, Tanswell KA. Vitamin D stimulates DNA synthesis in alveolar type II cells. Biochim Biophys Acta 1221: 159–166, 1993.
25. Evans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placental-decidual function. J Soc Gynecol Invest 11: 263–271, 2004.
26. Evans KN, Nguyen L, Chan J, Innes BA, Bulmer JN, Kilby MD, Hewison M. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod 75: 816–822, 2006.
27. Farrell CJL, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods. Clin Chem 58: 531–542, 2012.
28. Foong RE, Shaw NC, Berry LJ, Hart PH, Gorman S, Zosky GR. Vitamin D deficiency causes airway hyperresponsiveness, increases airway smooth muscle mass, and reduces TGF-B expression in the lungs of female BALB/c mice. Physiol Rep 2: 1–12, 2014.
29. Fujisawa K, Umesono K, Kikawa Y, Shigematsu Y, Taketo A, Mayumi M, Inunzuka M. Identification of a response element for vitamin D3 and retinoic acid in the promoter region of the human fructose-l,6-bisphosphatase gene. J Biochem 127: 373–382, 2000.
30. Gaultier C, Harf A, Balmain N, Cuisinier-Gleizes P, Mathieu H. Lung mechanics in rachitic rats. Am Rev Respir Dis 130: 1108–1110, 1984.
31. Gizak A, Rakus D, Kolodziej J, Zabel M, Ogorzalek A, Dzugaj A. Human lung fructose-1,6-bisphosphatase is localized in pneumocytes II. Histol Histopathol 16: 53–55, 2001.
32. Glasgow JFT, Thomas PS. Rachtic respiratory distress in small preterm infants. Arch Dis Child 52: 268–273, 1977.
33. Goyal R, Zhang L, Blood AB, Baylink DJ, Longo LD, Oshiro B, Mata-Greenwood E. Characterization of an animal model of pregnancyinduced vitamin D deficiency due to metabolic gene dysregulation. Am J Physiol Endocrinol Metab 306: E256–E266, 2014.
34. Gray TK, Lowe W, Lester GE. Vitamin D and pregnancy—the maternal- fetal metabolism of vitamin D. Endocr Rev 2: 264–274, 1981.
35. Griffin M, Bhandari R, Hamilton G, Chan YC, Powell JT. Alveolar type II cell-fibroblast interactions, synthesis and secretion of surfactant and type I collagen. J Cell Sci 105: 423–432, 1993.
36. Hadchouel A, Franco-Montoya ML, Delacourt C. Altered lung development in bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 100: 158–167, 2014.
37. Halliday HL. Surfactants: past, present and future. J Perinatol 28, Suppl 1: S47–S56, 2008.
38. Hallman M, Marttila R, Pertile R, Ojaniemi M, Haataja R. Genes and environment in common neonatal lung disease. Neonatology 91: 298–302, 2007.
39. Halloran BP. Cellular growth and differentiation during embryogenesis and fetal development. The role of vitamin D. Adv Exp Med Biol 352: 227–236, 1994.
40. Hart PH, Lucas RM, Walsh JP, Zosky GR, Whitehouse AJO, Zhu K, Allen KL, Kusel MM, Anderson D, Mountain JA. Vitamin D in fetal development. Findings from a birth cohort study. Pediatrics 135: e167– e173, 2015.
41. Hermansen CL, Lorah KN. Respiratory distress in the newborn. Am Fam Physician 76: 987–994, 2007.
42. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Mother D, Oxman AD, Savovic J, Schultz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343: 1–9, 2011.
43. Hooijmans CR, Rovers MM, de Vries R BM, Leernaars M, Ritskes- Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol 14: 1–9, 2014.
44. Hossain N, Kanani FH, Ramzan S, Kausar R, Ayaz S, Khanani R, Pal L. Obstetric and neonatal outcomes of maternal vitamin D supplementation: results of an open-label, randomized controlled trial of antenatal vitamin D supplementation in Pakistani women. J Clin Endocrinol Metab 99: 2448–2455, 2014.
45. Jobe AH. What is BPD in 2012 and what will BPD become? Early Hum Dev 88S2: S27–S28, 2012.
46. Kaushal M, Magon N. Vitamin D in pregnancy: A metabolic outlook. Indian J Endocrinol Metab 17: 76–82, 2013.
47. Kazemi A, Sharifi F, Jafari N, Mousavinasab N. High prevalence of vitamin D deficiency among pregnant women and their newborns in an Iranian population. J Womens Health 18: 835–839, 2009.
48. Kho AT, Sharma S, Qiu W, Gaedigk R, Klanderman B, Niu S, Anderson C, Leeder JS, Weiss ST, Tantisira. Vitamin D related genes in lung development and asthma pathogenesis. BMC Med Genom 6: 1–9, 2013.
49. Khubchandani KR, Snyder JM. Surfactant protein A (SP-A)-the alveolus and beyond. FASEB J 15: 59–69, 2001.
50. Kimball S, Fuleihan GEH, Reinhold V. Vitamin D: A growing perspective. Crit Rev Clin Lab Sci 45: 339–414, 2008.
51. Koroglu OA, Onay H, Cakmak B, Bilgin B, Yalaz M, Tunc S, Ozkinay F, Kultursay N. Association of vitamin D receptor gene polymorphisms and bronchopulmonary dysplasia. Pediatr Res 76: 171– 176, 2014.
52. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, Fanaroff AA, Stark A, Carlo W, Tyson JE, Donovan EF, Shankaran S, Stevenson DK. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 107: 1–8, 2001.
53. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62: e1–134, 2009.
54. Liebeskind A, Srinivasan S, Kaetzel D, Bruce M. Retinoic acid stimulates immature lung fibroblast growth via a PDGF-mediated autocrine mechanism. Am J Physiol Lung Cell Mol Physiol 279: L81–L90, 2000.
55. Litonjua AA, Lange NE, Carey VJ, Brown S, Laranjo N, Harshfield BJ, O’Connor GT, Sandel M, Strunk RC, Bacharier LB, Zeiger RS, Schatz M, Hollis BW, Weiss ST. The Vitamin D Antenatal Asthma Reduction Trial (VDAART): rationale, design, and methods of a randomized, controlled trial of vitamin D supplementation in pregnancy for the primary prevention of asthma and allergies in children. Contemp Clin Trials 38: 37–50, 2014.
56. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 120: 1031–1035, 2007.
57. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770– 1773, 2006.
58. Lyra PPR, Diniz EMA, Sandes KA, Angelo ALD, Machado TMB, Cardeal M. Surfactant protein B gene polymorphism in preterm babies with respiratory distress syndrome. Braz J Med Biol Res 44: 66–72, 2011.
59. Ma CC, Ma S. The role of surfactant in respiratory distress syndrome. Open Respir Med J 6: 44–53, 2012.
60. Mandell E, Seedorf G, Gien J, Abman SH. Vitamin D treatment improves survival and infant lung structure after intra-amniotic endotoxin exposure in rats: potential role for the prevention of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 306: L420–L428, 2014.
61. Marin L, Dufour M, Nguyen T, Tordet C, Garabedian M. Maturational changes induced by 1 _,25-dihydroxyvitamin D3 in type II cells from fetal rat lung explants. Am J Physiol Lung Cell Mol Physiol 265: L45–L52, 1993.
62. Marin L, Dufour M, Tordet C, Nguyen T. 1,25(OH)2D3 stimulates phospholipid biosynthesis and surfactant release in fetal rat lung explants. Biol Neonate 57: 257–260, 1990.
63. Maslova E, Hansen S, Jensen CB, Thorne-Lyman AL, Strøm M, Olsen SF. Vitamin D intake in mid-pregnancy and child allergic disease— a prospective study in 44, 825. Danish mother-child pairs. BMC Pregnancy Childbirth 13: 1–14, 2013.
64. Maslova E, Hansen S, Thorne-Lyman AL, Jensen CB, Strøm M, Cohen A, Nielsen NO, Olsen SF. Predicted vitamin D status in midpregnancy and child allergic disease. Pediatr Allergy Immunol 25: 706–713, 2014.
65. Mathieu C. Vitmain D and the immune system: getting it right. IBMS BoneKEY 8: 178–186, 2011.
66. McCarthy RA, McKenna MJ, Oyefeso O, Uduma O, Murray BF, Brady JJ, Kilbane MT, Murphy JF, Twomew A, O’Donnell CP, Murphy NP, Molloy EJ. Vitamin D nutrition status in preterm infants and response to supplementation. Br J Nutr 110: 156–163, 2012.
67. Mulberg AE, Murphy D, Dunne J, Mathis LL. Pediatric Drug Development. Hoboken, NJ: John Wiley and Sons, 2013.
68. Mulder EEM, Lopriore E, Rijken M, Walther FJ, andte Pas AB. Changes in respiratory support of preterm infants in the last decade: are we improving? Neonatology 101: 247–253, 2012.
69. Nguyen M, Guillozo H, Garabedian M, Balsan S. Lung as a possible additional target organ for vitamin D during fetal life in the rat. Biol Neonate 52: 232–240, 1987.
70. Nguyen M, Guillozo H, Marin L, Dufour M, Tordet C, Pike JW, Garabedian M. 1,25-dihydroxyvitamin D3 receptors in Rat lung during the perinatal period. Regulation and immunohistochemical localization. Endocrinology 127: 1755–1762, 1990.
71. Nguyen M, Guillozo H, Marin L, Tordet C, Koite S, Garabedian M. Evidence for a vitamin D paracrine system regulating maturation of developing rat lung epithelium. Am J Physiol 15: L392–L399, 1996.
72. Nguyen M, Trubert CL, Rizk-Rabin M, Rehan VK, Besancon F, Cayre YE, Garabedian M. 1,25-Dihydroxyvitamin D3 and fetal lung maturation: immunogold detection of VDR expression in pneumocytes type II cells and effect on fructose 1,6 bisphosphatase. J Steroid Biochem Mol Biol89–90: 93–97, 2004.
73. O’Reilly M, Thebaud B. Animal models of bronchopulmonary dysplasia. The term rat models. Am J Physiol Lung Cell Mol Physiol 307: L948–L958, 2014.
74. Parkes I, Schenker JG, Shufaro Y. Parathyroid and calcium metabolism disorders during pregnancy. Gynecol Endocrinol 29: 515–519, 2013.
75. Perez-Lopez FR. Vitamin D: The secosteroid hormone and human reproduction. Gynecol Endocrinol 23: 13–24, 2007.
76. Phokela SS, Peleg S, Moya FR, Alcorn JL. Regulation of human pulmonary surfactant protein gene expression by 1 _,25-dihydroxyvitamin D 3. Am J Physiol Lung Cell Mol Physiol 289: L617–L626, 2005.
77. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 9: 941–955, 2010.
78. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi A, Powe NR, Thadhani R. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369: 1991–2000, 2013.
79. Reed D, Bakketeig L, Nugent R. The epidemiology of respiratory distress syndrome in Norway. Am J Epidemiol 104: 299–310, 1978.
80. Rehan VK, Torday JS, Peleg S, Gennaro L, Vouros P, Padbury J, Rao DS, Reddy GS. 1,25(OH)D-3-epi-vitamin D3, a natural metabolite of 1 alpha,25-dihydroxy vitamin D 3. Mol Genet Metab 76: 46–56, 2002.
81. Reichel H, Bishop JE, Koeffler HP, Norman AW. Evidence for 1,25-dihydroxyvitamin D 3 production by cultured porcine alveolar macrophages. Mol Cell Endocrinol 75: 163–167, 1991.
82. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth (Review). Cochrane Database Syst Rev 19: CD004454, 2006.
83. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo- Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Ross AC, Shapses SA, Taylor CL. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 97: 1146–1152, 2012.
84. Sachan A, Gupta R, Das V, Agarwal A, Awasthi PK, Bhatia V. High prevalence of vitamin D deficiency among pregnant women and their newborns in northern India. Am J Clin Nutr 81: 1060–1064, 2005.
85. Sakurai R, Shin E, Fonseca S, Sakurai T, Litonjua AA, Weiss ST, Torday JS, Rehan VK. 1_,25(OH)2D3 and its 3-epimer promote rat lung alveolar epithelial-mesenchymal interactions and inhibit lipofibroblast apoptosis. Am J Physiol Lung Cell Mol Physiol 297: L496–L505, 2009.
86. Samtani MN, Pyszczynski NA, Dubois DC, Almon RR, Jusko WJ. Modeling glucocorticoid-mediated fetal lung maturation: I. Temporal patterns of corticosteroids in rat pregnancy. J Pharmacol Exp Ther 317: 117–126, 2005.
87. Schräder M, Bendik I, Becker-Andre M, Carlberg C. Interaction between retinoic acid and vitamin D signaling pathways. J Biol Chem 268: 17830–17836, 1993.
88. Shah PS. Current perspectives on the prevention and management of chronic lung disease in preterm infants. Pediatr Drugs 5: 463–480, 2003.
89. Shah SS, Ohlsson A, Halliday HL, Shah VS. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev 16: CD002058, 2012.
90. Shannon JM, Hyatt BA. Epithelial-mesenchymal interactions in the developing lung. Annu Rev Physiol 66: 625–645, 2004.
91. Sharma S, Chhabra D, Kho AT, Hayden LP, Weiss ST. The genomic of asthma. Thorax 69: 481–487, 2014.
92. Smart DE, Princivalle MB. Improving RDS treatment with current drugs. J Matern Fetal Neonatal Med 25: 1209–1211, 2012.
93. Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 212: 381–416, 2007.
94. Sundar IK, Hwang JW, Wu S, Sun J, Rahman I. Deletion of vitamin D receptor leads to premature emphysema/COPD by increased matrix metalloproteinases and lymphoid aggregates formation. Biochem Biophys Res Commun 406: 127–133, 2011.
95. Tillis CC, Huang HW, Bi W, Pan S, Bruce SR, Alcorn JL. Glucocorticoid regulation of human pulmonary surfactant protein-B (SP-B) mRNA stability is independent of activated glucocorticoid receptor. Am J Physiol Lung Cell Mol Physiol 300: L940–L950, 2011.
96. Torday JS, Rehan VK. Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res 62: 2–7, 2007.
97. Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 37: 1–12, 2006.
98. Vandevijvere S, Amsalkhir S, Van Oyen H, Moreno-Reyes R. High prevalence of vitamin D deficiency in pregnant women: a national cross-sectional survey. PloS One 7: e43868, 2012.
99. Vendettuoli V, Bellù R, Zanini R, Mosca F, Gagliardi L. Changes in ventilator strategies and outcomes in preterm infants. Arch Dis Child Fetal Neonatal Ed 99: F321–F324, 2014.
100. Wagner CL, McNeil R, Hamilton SA, Winkler J, Cook CR, Warner G, Bivens B, Davis DJ, Smith PG, Murphy M, Shary JR, Hollis BW. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am J Obstet Gynecol 208: e1–e13, 2013.
101. Wang T, Zhang F, Richards J, Kestenbaum B, van Meurs J, Berry D, Kiel D, Streeten E, Ohlsson C, Koller D, Peltonen L, Cooper D, O’Reilly P, Houston D, Glazer N, Vandenput L, Peacock M, Shi J, Rivadeneira F, McCarthy M, Anneli P, de Boer I, Mangino M, Kato B, Smyth D, Booth S, Jacques P, Burke G, Goodarzi M, Cheung CL, Wolf M, Rice K, Goltzman D, Hidiroglou N, Ladouceur M, Wareham N, Hocking L, Hart D, Arden N, Cooper C, Malik S, Fraser W, Hartikainen AL, Zhai G, Macdonald H, Forouhi N, Loos R, Reid D, Hakim A, Dennison E, Liu Y, Power C, Stevens H, Jaana L, Vasan R, Soranzo N, Bojunga J, Psaty B, Lorentzon M, Foroud T, Harris T, Hofman A, Jansson JO, Cauley J, Uitterlinden A, Gibson Q, Järvelin MR, Karasik D, Siscovick D, Econs M, Kritchevsky S, Florez J, Todd J, Dupuis J, Hyppönen E, Specto T. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376: 180–188, 2010.
102. Wang Y, Becklund BR, DeLuca HF. Identification of a highly specific and versatile vitamin D receptor antibody. Arch Biochem Biophys 494: 166–177, 2010.
103. Wang Y, Zhu J, DeLuca HF. Where is the vitamin D receptor? Arch Biochem Biophys 523: 123–133, 2012.
104. Weisman Y. Maternal, fetal and neonatal vitamin D and calcium metabolism during pregnancy and lactation. Endocr Dev 6: 34–49, 2003.
105. Yang CY, Leung PS, Adamopoulos IE, Gershwin ME. The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol 45: 217–226, 2013.
106. Yazdanpanah M, Bailey D, Walsh W, Wan B, Adeli K. Analytical measurement of serum 25-OH-vitamin D3, 25-OH-vitamin D2 and their C3-epimers by LC-MS/MS in infant and pediatric specimens. Clin Biochem 46: 1264–1271, 2013.
107. Yurt M, Liu J, Sakurai R, Gong M, Husain SM, Siddiqui MA, Husain M, Villarreal P, Akcay F, Torday JS, Rehan VK. Vitamin D blocks pulmonary structural and foundational changes in a rat model of perinatal vitamin D deficiency. Am J Physiol Lung Cell Mol Physiol 307: L859–L867, 2014.
108. Zosky GR, Berry LJ, Elliot JG, James AL, Gorman S, Hart PH. Vitamin D deficiency causes deficits in lung function and alters lung structure. Am J Respir Crit Care Med 183: 1336–1343, 2011.
109. Zosky GR, Hart PH, Whitehouse AJO, Kusel MM, Ang W, Foong RE, Chen L, Holt PG, Sly PD, Hall GL. Vitamin D deficiency at 16 to 20 weeks’ gestation is associated with impaired lung function and asthma at 6 years of age. Ann Am Thorac Soc 11: 571–577, 2014.